PharmaBoardroom

The chairman of BioSingapore, Dr. Siew Hwa Ong, discusses the opportunities and challenges facing biotech SMEs in Singapore, government efforts to…

The executive director of A*STAR’s Biomedical Research Council, Dr. Benjamin Seet highlights several remarkable milestones that the organization has…

Switzerland’s pharma industry is moving beyond staid conservatism and embracing risk in order to compete internationally and foster a new culture of…

Patricia Ostrosky, general director of the Institute of Biomedical Research in Mexico, details current research subjects and calls for greater…

Sandoz’s ambitious strategy in Mexico includes aggressive product launches in biosimilars and oncology, a heightened focus on the institutional…

Founded in 2011, APC has grown to be the largest process development company in Ireland. It is the largest employer of PhD Chemical…

FDI into Irish pharma has almost exclusively targeted in biologics production over the last few years, largely due to Ireland’s skilled workforce of…

Since gaining independence in 1965, Singapore has invested heavily in moving beyond being a mere supplier of low cost labor like many of its Asian…

Merck Czech Republic’s MD reveals his plan to double Merck operations within the next five years and talks about the impact of the recent…

Rafael Suarez, general manager of Ferring in Mexico, explains how the Swiss biopharmaceutical company is adapting to the recent dynamics affecting…

As President of Biopharma Activities for Merck in France, Pierre-Henry Longeray reveals how France is the third ranked affiliate after the US and…

The following chart illustrates the various bottlenecks restraining the development of France's pharmaceutical industry, including lack of…